Hareth Nahi

Hareth Nahi

UNVERIFIED PROFILE

Are you Hareth Nahi?   Register this Author

Register author
Hareth Nahi

Hareth Nahi

Publications by authors named "Hareth Nahi"

Are you Hareth Nahi?   Register this Author

67Publications

1360Reads

-Profile Views

Infectious complications and NK cell depletion following daratumumab treatment of Multiple Myeloma.

PLoS One 2019 13;14(2):e0211927. Epub 2019 Feb 13.

Division of Hematology, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0211927PLOS
February 2019

A Pilot, Exploratory, Randomized, Phase II Safety Study Evaluating Tumor Cell Mobilization and Apheresis Product Contamination in Patients Treated with Granulocyte Colony-Stimulating Factor Alone or Plus Plerixafor.

Biol Blood Marrow Transplant 2019 Jan 24;25(1):34-40. Epub 2018 Aug 24.

Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791183049
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2018.08.020DOI Listing
January 2019

Author Correction: Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma.

Nat Commun 2019 01 10;10(1):213. Epub 2019 Jan 10.

Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41467-018-08107-8
Publisher Site
http://dx.doi.org/10.1038/s41467-018-08107-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328616PMC
January 2019

Functional Assessment for Clinical Use of Serum-Free Adapted NK-92 Cells.

Cancers (Basel) 2019 Jan 10;11(1). Epub 2019 Jan 10.

Center for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Karolinska Institutet, 141 83 Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://www.mdpi.com/2072-6694/11/1/69
Publisher Site
http://dx.doi.org/10.3390/cancers11010069DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356567PMC
January 2019

Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma.

Nat Commun 2018 09 13;9(1):3707. Epub 2018 Sep 13.

Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41467-018-04989-w
Publisher Site
http://dx.doi.org/10.1038/s41467-018-04989-wDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6137048PMC
September 2018

Case Report: Treatment of light-chain amyloidosis with daratumumab monotherapy in two patients.

Eur J Haematol 2018 Apr 1;100(4):386-388. Epub 2018 Jan 1.

Department of Medicine, Karolinska Institutet Department of Medicine Huddinge, Huddinge, Sweden.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/ejh.13008
Publisher Site
http://dx.doi.org/10.1111/ejh.13008DOI Listing
April 2018

Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma.

N Engl J Med 2016 10;375(14):1319-1331

From the National and Kapodistrian University of Athens, Athens (M.A.D.); Institut Català d'Oncologia, Institut Josep Carreras, Hospital Germans Trias I Pujol, Barcelona (A.O.), and Clínica Universidad de Navarra-Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, Pamplona (J.S.-M.) - both in Spain; Karolinska Institute and the Department of Medicine, Division of Hematology, Karolinska University Hospital at Huddinge, Stockholm (H.N.); Tom Baker Cancer Centre, University of Calgary, Calgary, AB (N.J.B.), and the Cancer Clinical Research Unit, Princess Margaret Cancer Centre, Toronto (D.R.) - both in Canada; Levine Cancer Institute-Carolinas HealthCare System, Charlotte, NC (S.Z.U.); the Department of Haematology, University College London Hospitals NHS Trust, London (N.R.); the Department of Lymphoma-Myeloma, University of Texas M.D. Anderson Cancer Center, Houston (R.Z.O.); the Department of Hematology and Stem Cell Transplantation, Poznan University of Medical Sciences, Poznan, Poland (M.K.); the Department of Hematology, Japanese Red Cross Medical Center, Tokyo (K.S.); Vejle Hospital and University of Southern Denmark, Vejle (T.P.), and Genmab, Copenhagen (S.L.) - both in Denmark; the Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea (S.-S.Y.); the Hematology Department, Hadassah-Hebrew University Medical Center, Jerusalem (D.B.Y.); Dana-Farber Cancer Institute, Harvard Medical School, Boston (P.G.R.); University Hospital Heidelberg and the German Cancer Research Center, Heidelberg, Germany (H.G.); Janssen Research and Development, Spring House, PA (N.Z.K., L.O., C.C., X.Q., M.G., T.A.); and the Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France (P.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1607751DOI Listing
October 2016

Re-challenging with anti-CD38 monotherapy in triple-refractory multiple myeloma patients is a feasible and safe approach.

Br J Haematol 2016 08 12;174(3):473-7. Epub 2015 Oct 12.

Centre for Haematology and Regenerative Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13776DOI Listing
August 2016

Deletion of Chromosomal Region 8p21 Confers Resistance to Bortezomib and Is Associated with Upregulated Decoy TRAIL Receptor Expression in Patients with Multiple Myeloma.

PLoS One 2015 17;10(9):e0138248. Epub 2015 Sep 17.

Center for Hematology and Regenerative Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden; Center for Diseases of Aging, Vaccine and Gene Therapy Institute of Florida, Port St. Lucie, Florida, United States of America; Haematology Centre, Karolinska University Hospital, Huddinge, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0138248PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4574561PMC
June 2016

Cost effectiveness of pomalidomide in patients with relapsed and refractory multiple myeloma in Sweden.

Acta Oncol 2016 May 17;55(5):554-60. Epub 2015 Nov 17.

b The Swedish Institute for Health Economics (IHE) , Lund , Sweden .

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.3109/0284186X.2015.1
Publisher Site
http://dx.doi.org/10.3109/0284186X.2015.1096021DOI Listing
May 2016

American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma.

Biol Blood Marrow Transplant 2015 Dec 30;21(12):2039-2051. Epub 2015 Sep 30.

University of Pennsylvania Abramson Cancer Center, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2015.09.016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4757494PMC
December 2015

Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma.

N Engl J Med 2015 Sep 26;373(13):1207-19. Epub 2015 Aug 26.

From the Department of Hematology, University Medical Center Utrecht, Utrecht (H.M.L., M.C.M., N.W.C.J.D.), and the Department of Hematology, VU University Medical Center, Amsterdam (H.M.L., N.W.C.J.D.) - both in the Netherlands; Vejle Hospital and University of Southern Denmark, Vejle (T.P., J.K.), and Rigshospitalet and University of Copenhagen (P.G., U.L.) and Genmab (N.L., S.L., L.B., N.B.), Copenhagen - all in Denmark; Dana-Farber Cancer Institute, Harvard Medical School, Boston (J.P.L., P.G.R.); Karolinska Institute and the Department of Medicine, Division of Hematology, Karolinska University Hospital at Huddinge, Stockholm (H.N.), and Skåne University Hospital and Lund University, Lund (M.H.) - all in Sweden; Myeloma Unit, Division of Hematology, University of Turin, Turin, Italy (A.P.); Janssen Research and Development, Spring House, PA (T.A., C.M.U., A.K.S.); and Janssen Research and Development, Raritan, NJ (I.K., J.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1506348DOI Listing
September 2015

TP53 mutations and MDM2(SNP309) identify subgroups of AML patients with impaired outcome.

Eur J Haematol 2015 Apr 1;94(4):355-62. Epub 2014 Oct 1.

Department of Medical and Health Sciences, Linköping University, Linköping, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12438DOI Listing
April 2015

A genealogical and clinical study of the phenotypical variation within the Swedish transthyretin His88Arg (p. His108Arg) amyloidosis family.

Eur J Med Genet 2015 Apr 24;58(4):211-5. Epub 2015 Feb 24.

Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejmg.2015.02.005DOI Listing
April 2015

The use of novel drugs can effectively improve response, delay relapse and enhance overall survival in multiple myeloma patients with renal impairment.

PLoS One 2014 8;9(7):e101819. Epub 2014 Jul 8.

Department of Medicine, Karolinska Institutet Huddinge, Stockholm, Sweden; Hematology Center, Karolinska University Hospital Huddinge, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0101819PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4086950PMC
March 2015

Bendamustine in combination with high-dose radiotherapy and thalidomide is effective in treatment of multiple myeloma with central nervous system involvement.

Eur J Haematol 2014 7;92(5):454-5. Epub 2014 Mar 7.

Department of Medicine, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/ejh.12247
Publisher Site
http://dx.doi.org/10.1111/ejh.12247DOI Listing
December 2014

Impact of ABCB1 single nucleotide polymorphisms 1236C>T and 2677G>T on overall survival in FLT3 wild-type de novo AML patients with normal karyotype.

Br J Haematol 2014 Dec 23;167(5):671-80. Epub 2014 Aug 23.

Clinical Pharmacology, Division of Drug Research, Department of Medical and Health Sciences, Faculty of Health Sciences, Linköping University, Linköping, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13097DOI Listing
December 2014

European perspective on multiple myeloma treatment strategies in 2014.

Oncologist 2014 Aug 25;19(8):829-44. Epub 2014 Jul 25.

Department of Oncology, Hematology and Palliative Care, Wilhelminenspital, Vienna, Austria; Department of Hematology, Erasmus Medical Center, Rotterdam, The Netherlands; Institute of Cancer Research, Royal Marsden Hospital, London, United Kingdom; Department of Hematology, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clinic, Barcelona, Spain; Divisione di Ematologia dell'Università di Torino, Azienda Ospedaliera S. Giovanni Battista, Ospedale Molinette, Turin, Italy; Institute of Hematology and Medical Oncology, Seragnoli, Bologna, Italy; Haemato-Oncology Unit, Royal Marsden Hospital, Surrey, United Kingdom; Hematology Service, University Hospital La Fe, Valencia, Spain; Department of Hematology, University Hospital, Leuven, Belgium; Department of Clinical Therapeutics, University of Athens School of Medicine, Athens, Greece; Universitätsklinik Würzburg, Medizinische Klinik und Poliklinik II, Würzburg, Germany; Service d'Hématologie, Centre Hospitalier Universitaire, Lille, France; Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany; University Hospital, Nantes, France; Karolinska Institute, Stockholm, Sweden; Department of Hematology, Center Lillebaelt, University of Southern Denmark, Odense, Denmark; Clinica Universidad de Navarra, Centro Investigaciones Medicas Aplicada, Pamplona, Spain; Department of Hemato-oncology, University of Ostrava, Ostrava, Czech Republic; University of Giessen, Giessen, Germany.

View Article

Download full-text PDF

Source
http://szpiczak.org/lang/aktualnosci/publikacje/rok_2014/The
Web Search
http://theoncologist.alphamedpress.org/cgi/doi/10.1634/theon
Publisher Site
http://dx.doi.org/10.1634/theoncologist.2014-0042DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4122482PMC
August 2014

Successful treatment of recurrent malignancy-associated hemophagocytic lymphohistiocytosis with a modified HLH-94 immunochemotherapy and allogeneic stem cell transplantation.

Med Oncol 2012 Jun 29;29(2):1231-6. Epub 2011 Apr 29.

Hematology Center Karolinska, Karolinska University Hospital Huddinge, 141 86 Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12032-011-9963-3DOI Listing
June 2012

Acquired hemophagocytic lymphohistiocytosis associated with multiple myeloma.

Med Oncol 2011 Jun 1;28(2):539-43. Epub 2010 Apr 1.

Hematology Center Karolinska, M54, Karolinska University Hospital Huddinge, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12032-010-9484-5DOI Listing
June 2011

Constitutional inv(3) in myelodysplastic syndromes.

Leuk Res 2010 Dec 9;34(12):1627-9. Epub 2010 Jun 9.

Department of Medicine, Karolinska Institutet Huddinge, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2010.05.014DOI Listing
December 2010

Clinical-grade, large-scale, feeder-free expansion of highly active human natural killer cells for adoptive immunotherapy using an automated bioreactor.

Cytotherapy 2010 Dec 26;12(8):1044-55. Epub 2010 Aug 26.

Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/14653249.2010.504770DOI Listing
December 2010

Low p14ARF expression in de novo acute myeloid leukemia with normal karyotype is associated with poor survival.

Leuk Lymphoma 2009 Sep;50(9):1512-8

Department of Medicine and Haematology, Karolinska University Hospital, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190903111914DOI Listing
September 2009

Impact of chromosome 13 deletion and plasma cell load on long-term survival of patients with multiple myeloma undergoing autologous transplantation.

Oncol Rep 2009 Jul;22(1):137-42

Hematology Center, Karolinska University Hospital and Division of Hematology, Department of Medicine, Karolinska University Hospital/Huddinge, Stockholm, Sweden.

View Article

Download full-text PDF

Source
July 2009

The FLT3 inhibitor PKC412 in combination with cytostatic drugs in vitro in acute myeloid leukemia.

Cancer Chemother Pharmacol 2008 Aug 25;62(3):439-48. Epub 2007 Oct 25.

Department of Hematology, Karolinska University Hospital Huddinge, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-007-0623-4DOI Listing
August 2008

Autologous antitumor activity by NK cells expanded from myeloma patients using GMP-compliant components.

Blood 2008 Mar 11;111(6):3155-62. Epub 2008 Jan 11.

Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2007-09-110312DOI Listing
March 2008

Chromosomal aberrations in 17p predict in vitro drug resistance and short overall survival in acute myeloid leukemia.

Leuk Lymphoma 2008 Mar;49(3):508-16

Department of Haematology, Karolinska Institute at Huddinge University Hospital, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190701861645DOI Listing
March 2008

Topoisomerase IIalpha mRNA and protein expression vs. in vitro drug resistance and clinical outcome in acute leukaemia.

Int J Oncol 2007 Jul;31(1):153-60

Department of Medicine, Orebro University Hospital, 701 85 Orebro, Sweden.

View Article

Download full-text PDF

Source
July 2007

Vaccination of patients with haematological malignancies with one or two doses of influenza vaccine: a randomised study.

Br J Haematol 2005 Jul;130(1):96-8

Haematology Centre, Karolinska University Hospital, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2005.05582.xDOI Listing
July 2005